Palogic Value Management »

Ocuphire Pharma shares owned by Palogic Value Management

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Palogic Value Management from 13F filings

Historical chart of Palogic Value Management investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Palogic Value Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Palogic Value Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $296k 65k 4.55

More positions owned by Palogic Value Management

Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Exxon Mobil Corporation (XOM)
Ssga Active Etf Tr State Street Bla (SRLN)
Bhp Billiton Sponsored Ads (BHP)
Microsoft Corporation (MSFT)
Open Lending Corp (LPRO)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Abbvie (ABBV)
Shell Spon Ads (SHEL)
Amazon (AMZN)
Health Catalyst (HCAT)

View all positions for Palogic Value Management

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
Balyasny Asset Management
Millennium Management
Vanguard Capital Management
Marshall Wace
Boxer Capital Management
ADAR1 Capital Management
Perceptive Advisors
Nantahala Capital Management
Woodline Partners
Boothbay Fund Management
Opaleye Management
Farallon Capital Management

View all funds holding Ocuphire Pharma